RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS
Clinical trials for RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS trials appear
Sign up with your email to follow new studies for RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells target cancer in groundbreaking lymphoma trial
Disease control OngoingThis early-phase study is testing a new type of cell therapy for patients with high-risk or returning B-cell non-Hodgkin lymphoma. After receiving a stem cell transplant, patients get an infusion of their own immune cells that have been genetically modified in a lab to better fin…
Matched conditions: RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New strategy aims to tame dangerous virus after cancer transplant
Disease control OngoingThis study is testing a personalized plan to manage cytomegalovirus (CMV), a common and potentially serious infection, in patients who have received a donor stem cell transplant for blood cancers or disorders. The plan involves closely monitoring the virus level and the patient's…
Matched conditions: RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC